BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Xadago (Safinamide) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Xadago (Safinamide)\, from ClinicalTrials
 .gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07761936-1777@assetmemo.bio
DTSTAMP:20261121T010134Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Xadago (Safinamide): Phase 3 readout est. (NCT07761936)
DESCRIPTION:Xadago (Safinamide)\, phase 3\, Parkinson's Disease.\nStudy: Sa
 finamide vs Placebo for Pain in Patients With Parkinson's Disease and Moto
 r Fluctuations\nEstimated primary completion: December 2027. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/safinamide#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07761936
URL:https://assetmemo.bio/drug/safinamide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
